New Year Bumper Sale @ Rs. 1 X
Befer Oral Drops is an allopathic medicine The correct dosage of Befer Oral Drops depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Befer Oral Drops is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Befer Oral Drops safe for pregnant women?
Pregnant women can take Befer Oral Drops without worrying about any side effects.
Is the use of Befer Oral Drops safe during breastfeeding?
Breastfeeding women can safely use Befer Oral Drops.
What is the effect of Befer Oral Drops on the Kidneys?
Befer Oral Drops does not damage the kidneys.
What is the effect of Befer Oral Drops on the Liver?
Befer Oral Drops is not harmful for the liver.
What is the effect of Befer Oral Drops on the Heart?
There are no any side effects of Befer Oral Drops for the heart.
Befer Oral Drops should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Befer Oral Drops unless your doctor advises you to do so -
Is this Befer Oral Drops habit forming or addictive?
Befer Oral Drops is not addictive in nature.
Interaction between Food and Befer Oral Drops
Taking Befer Oral Drops with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Befer Oral Drops
Due to lack of research, there is no information about the side effects of taking Befer Oral Drops with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 609-611